BioSpace News Archive

Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020

VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced the completion of patient enrollment in a Phase 4 clinical study designed to evaluate the safety and efficacy of Qsymia® (phentermine and topiramate extended-release) capsules CIV in adolescents between the ages of 12 and 17 years who are obese (NCT# 03922945).

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today provided a business update and reported financial results for the fourth quarter and year ended December 31, 2019.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the fourth quarter and year ending December 31, 2019, and provided a corporate update.

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced financial results for the fourth quarter and full year ended December 31, 2019, and provided a corporate update.

Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), will be featured as a presenting company during the 2020 LD Micro Virtual Investor Conference.

Primmune Therapeutics today announced that it has raised $7 million in seed financing to support the development of novel orally-administered, small molecule toll-like receptor 7 (TLR7) agonists for long-term systemic activation of innate immunity.

InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida, on March 11 at 1:35 pm EST.

IQ4I Research & Consultancy published a new report on “Proteomics Global Market – Forecast To 2026".

New Thermo Scientific Vanquish Core HPLC System maximizes the delivery of precise results with simple, seamless method transfer